These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7662574)

  • 1. Adrenal function following topical steroid treatment in children with atopic dermatitis.
    Patel L; Clayton PE; Addison GM; Price DA; David TJ
    Br J Dermatol; 1995 Jun; 132(6):950-5. PubMed ID: 7662574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis.
    Ellison JA; Patel L; Ray DW; David TJ; Clayton PE
    Pediatrics; 2000 Apr; 105(4 Pt 1):794-9. PubMed ID: 10742322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
    Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
    Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
    Vernon HJ; Lane AT; Weston W
    J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood.
    Queille C; Pommarede R; Saurat JH
    Pediatr Dermatol; 1984 Jan; 1(3):246-53. PubMed ID: 6494068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
    Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Risk of Adrenal Insufficiency After Use of Low- to Moderate-Potency Topical Corticosteroids for Children With Atopic Dermatitis.
    Davallow Ghajar L; Wood Heickman LK; Conaway M; Rogol AD
    Clin Pediatr (Phila); 2019 Apr; 58(4):406-412. PubMed ID: 30694073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical function in patients with severe atopic dermatitis.
    Matsuda K; Katsunuma T; Iikura Y; Kato H; Saito H; Akasawa A
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):35-9. PubMed ID: 10923602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion)].
    Ernst TM
    Z Hautkr; 1986; 61 Suppl 1():74-9. PubMed ID: 3010589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal steroid responsiveness in atopic dermatitis patients: therapeutic implications.
    Charlesworth EN
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):3-4. PubMed ID: 10923597
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
    Eichenfield LF; Basu S; Calvarese B; Trancik RJ
    Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisone butyrate 0.1% in treating children with atopic dermatitis.
    Eichenfield L; Ellis CN; Fivenson D; Hebert AA; Dromgoole S; Piacquadio D
    Pediatr Dermatol; 2007; 24(1):81-4. PubMed ID: 17300659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical function during prolonged treatment with clobetasone butyrate in children with chronic atopic dermatitis and elevated IgE levels.
    Boner AL; Richelli C; De Stefano G; Antolini I; Aprili F; Mengoni M
    Int J Clin Pharmacol Res; 1985; 5(2):127-31. PubMed ID: 4018942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluocinolone acetonide 0.01% in peanut oil: safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3 months of age.
    Dohil MA; Alvarez-Connelly E; Eichenfield LF
    Pediatr Dermatol; 2009; 26(3):262-8. PubMed ID: 19706085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal function in children with atopic dermatitis treated with clobetasone butyrate and its clinical evaluation.
    Boner AL; Richelli C; De Stefano G; Valletta EA; Ferrari S; Mengoni M
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):118-20. PubMed ID: 2985514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months.
    Friedlander SF; Hebert AA; Allen DB;
    J Am Acad Dermatol; 2002 Mar; 46(3):387-93. PubMed ID: 11862174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.